SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

20 May 2024 Evaluate
The company witnessed a 21.73% growth in the revenue at Rs. 1712.85 millions for the quarter ended March 2024 as compared to Rs. 1407.13 millions during the year-ago period.A good growth in profit of 48.05% reported to Rs. 169.49  millions over Rs. 114.48 millions of corresponding previous quarter.Operating profit surged to 263.75 millions from the corresponding previous quarter of 187.77 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1712.85 1407.13 21.73 6309.56 5130.83 22.97 6309.56 5130.83 22.97
Other Income 44.40 23.34 90.23 134.68 99.65 35.15 134.68 99.65 35.15
PBIDT 263.75 187.77 40.46 915.70 702.07 30.43 915.70 702.07 30.43
Interest 2.76 1.64 68.29 11.03 7.86 40.33 11.03 7.86 40.33
PBDT 260.99 186.13 40.22 904.67 694.21 30.32 904.67 694.21 30.32
Depreciation 35.36 35.68 -0.90 134.44 123.64 8.74 134.44 123.64 8.74
PBT 225.63 150.45 49.97 770.23 570.57 34.99 770.23 570.57 34.99
TAX 56.14 35.97 56.07 188.79 144.13 30.99 188.79 144.13 30.99
Deferred Tax 10.93 -6.12 -278.59 15.35 0.63 2336.51 15.35 0.63 2336.51
PAT 169.49 114.48 48.05 581.44 426.44 36.35 581.44 426.44 36.35
Equity 103.99 104.63 -0.61 103.99 104.63 -0.61 103.99 104.63 -0.61
PBIDTM(%) 15.40 13.34 15.39 14.51 13.68 6.06 14.51 13.68 6.06

Windlas Biotech Share Price

868.60 -3.15 (-0.36%)
17-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1239.00
Cipla 1238.30
Zydus Lifesciences 938.00
Lupin 2321.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×